BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12892959)

  • 1. Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study.
    Steinsland H; Valentiner-Branth P; Gjessing HK; Aaby P; Mølbak K; Sommerfelt H
    Lancet; 2003 Jul; 362(9380):286-91. PubMed ID: 12892959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau.
    Steinsland H; Valentiner-Branth P; Perch M; Dias F; Fischer TK; Aaby P; Mølbak K; Sommerfelt H
    J Infect Dis; 2002 Dec; 186(12):1740-7. PubMed ID: 12447759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protection against enterotoxigenic Escherichia coli infections].
    Steinsland H; Valentiner-Branth P; Gjessing HK; Aaby P; Sommerfelt H; Mølbak K
    Ugeskr Laeger; 2004 Nov; 166(45):4051-3. PubMed ID: 15565966
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J; Svennerholm AM
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of enterotoxigenic Escherichia coli strains isolated from Nicaraguan children in hospital, primary care and community settings.
    Vilchez S; Becker-Dreps S; Amaya E; Perez C; Paniagua M; Reyes D; Espinoza F; Weintraub A
    J Med Microbiol; 2014 May; 63(Pt 5):729-734. PubMed ID: 24554743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against enterotoxigenic Escherichia coli.
    Svennerholm AM; Tobias J
    Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea.
    Rao MR; Wierzba TF; Savarino SJ; Abu-Elyazeed R; El-Ghoreb N; Hall ER; Naficy A; Abdel-Messih I; Frenck RW; Svennerholm AM; Clemens JD
    J Infect Dis; 2005 Feb; 191(4):562-70. PubMed ID: 15655780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective cohort study of enterotoxigenic Escherichia coli infections in Argentinean children.
    Viboud GI; Jouve MJ; Binsztein N; Vergara M; Rivas M; Quiroga M; Svennerholm AM
    J Clin Microbiol; 1999 Sep; 37(9):2829-33. PubMed ID: 10449460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh.
    Qadri F; Das SK; Faruque AS; Fuchs GJ; Albert MJ; Sack RB; Svennerholm AM
    J Clin Microbiol; 2000 Jan; 38(1):27-31. PubMed ID: 10618058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia.
    Oyofo BA; Subekti DS; Svennerholm AM; Machpud NN; Tjaniadi P; Komalarini TS; Setiawan B; Campbell JR; Corwin AL; Lesmana M
    Am J Trop Med Hyg; 2001 Aug; 65(2):120-4. PubMed ID: 11508385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for enterotoxigenic Escherichia coli: current status.
    Boedeker EC
    Curr Opin Gastroenterol; 2005 Jan; 21(1):15-9. PubMed ID: 15687879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal relatedness of enterotoxigenic Escherichia coli strains isolated from a cohort of young children in Guinea-Bissau.
    Steinsland H; Valentiner-Branth P; Aaby P; Mølbak K; Sommerfelt H
    J Clin Microbiol; 2004 Jul; 42(7):3100-7. PubMed ID: 15243067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
    Sack DA; Shimko J; Torres O; Bourgeois AL; Francia DS; Gustafsson B; Kärnell A; Nyquist I; Svennerholm AM
    Vaccine; 2007 May; 25(22):4392-400. PubMed ID: 17448578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
    Behrens RH; Cramer JP; Jelinek T; Shaw H; von Sonnenburg F; Wilbraham D; Weinke T; Bell DJ; Asturias E; Pauwells HL; Maxwell R; Paredes-Paredes M; Glenn GM; Dewasthaly S; Stablein DM; Jiang ZD; DuPont HL
    Lancet Infect Dis; 2014 Mar; 14(3):197-204. PubMed ID: 24291168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).
    Vidal RM; Muhsen K; Tennant SM; Svennerholm AM; Sow SO; Sur D; Zaidi AKM; Faruque ASG; Saha D; Adegbola R; Hossain MJ; Alonso PL; Breiman RF; Bassat Q; Tamboura B; Sanogo D; Onwuchekwa U; Manna B; Ramamurthy T; Kanungo S; Ahmed S; Qureshi S; Quadri F; Hossain A; Das SK; Antonio M; Mandomando I; Nhampossa T; Acácio S; Omore R; Ochieng JB; Oundo JO; Mintz ED; O'Reilly CE; Berkeley LY; Livio S; Panchalingam S; Nasrin D; Farag TH; Wu Y; Sommerfelt H; Robins-Browne RM; Del Canto F; Hazen TH; Rasko DA; Kotloff KL; Nataro JP; Levine MM
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007037. PubMed ID: 30608930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli: A prospective study among Finnish travellers.
    Turunen K; Antikainen J; Lääveri T; Kirveskari J; Svennerholm AM; Kantele A
    Travel Med Infect Dis; 2020; 38():101855. PubMed ID: 32846225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
    Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
    Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological cross-reactivity of heat-labile enterotoxins produced by enterotoxigenic and enteropathogenic strains of Escherichia coli.
    Klipstein FA; Engert RF; Short HB
    Immunology; 1980 Sep; 41(1):115-21. PubMed ID: 7000692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.